241 related articles for article (PubMed ID: 36634978)
1. Diabetes with poor-control HbA1c is cardiovascular disease 'risk equivalent' for mortality: UK Biobank and Hong Kong population-based cohort study.
Wan EYF; Yu EYT; Mak IL; Youn HM; Chan KS; Chan EWY; Wong ICK; Lam CLK
BMJ Open Diabetes Res Care; 2023 Jan; 11(1):. PubMed ID: 36634978
[TBL] [Abstract][Full Text] [Related]
2. Obesity, clinical, and genetic predictors for glycemic progression in Chinese patients with type 2 diabetes: A cohort study using the Hong Kong Diabetes Register and Hong Kong Diabetes Biobank.
Jiang G; Luk AO; Tam CHT; Lau ES; Ozaki R; Chow EYK; Kong APS; Lim CKP; Lee KF; Siu SC; Hui G; Tsang CC; Lau KP; Leung JYY; Tsang MW; Kam G; Lau IT; Li JK; Yeung VT; Lau E; Lo S; Fung SKS; Cheng YL; Chow CC; Pearson ER; So WY; Chan JCN; Ma RCW; ;
PLoS Med; 2020 Jul; 17(7):e1003209. PubMed ID: 32722720
[TBL] [Abstract][Full Text] [Related]
3. Associations between usual glycated haemoglobin and cardiovascular disease in patients with type 2 diabetes mellitus: A 10-year diabetes cohort study.
Wan EY; Yu EY; Chen JY; Wong IC; Chan EW; Lam CL
Diabetes Obes Metab; 2020 Dec; 22(12):2325-2334. PubMed ID: 32744402
[TBL] [Abstract][Full Text] [Related]
4. Nonalbuminuric Diabetic Kidney Disease and Risk of All-Cause Mortality and Cardiovascular and Kidney Outcomes in Type 2 Diabetes: Findings From the Hong Kong Diabetes Biobank.
Jin Q; Luk AO; Lau ESH; Tam CHT; Ozaki R; Lim CKP; Wu H; Jiang G; Chow EYK; Ng JK; Kong APS; Fan B; Lee KF; Siu SC; Hui G; Tsang CC; Lau KP; Leung JY; Tsang MW; Kam G; Lau IT; Li JK; Yeung VT; Lau E; Lo S; Fung S; Cheng YL; Chow CC; Huang Y; Lan HY; Szeto CC; So WY; Chan JCN; Ma RCW;
Am J Kidney Dis; 2022 Aug; 80(2):196-206.e1. PubMed ID: 34999159
[TBL] [Abstract][Full Text] [Related]
5. Glycated Hemoglobin, Prediabetes, and the Links to Cardiovascular Disease: Data From UK Biobank.
Welsh C; Welsh P; Celis-Morales CA; Mark PB; Mackay D; Ghouri N; Ho FK; Ferguson LD; Brown R; Lewsey J; Cleland JG; Gray SR; Lyall DM; Anderson JJ; Jhund PS; Pell JP; McGuire DK; Gill JMR; Sattar N
Diabetes Care; 2020 Feb; 43(2):440-445. PubMed ID: 31852727
[TBL] [Abstract][Full Text] [Related]
6. Associations Between Frailty and the Increased Risk of Adverse Outcomes Among 38,950 UK Biobank Participants With Prediabetes: Prospective Cohort Study.
Cao X; Li X; Zhang J; Sun X; Yang G; Zhao Y; Li S; Hoogendijk EO; Wang X; Zhu Y; Allore H; Gill TM; Liu Z
JMIR Public Health Surveill; 2023 May; 9():e45502. PubMed ID: 37200070
[TBL] [Abstract][Full Text] [Related]
7. Patient Empowerment Programme in primary care reduced all-cause mortality and cardiovascular diseases in patients with type 2 diabetes mellitus: a population-based propensity-matched cohort study.
Wong CK; Wong WC; Wan YF; Chan AK; Chung KL; Chan FW; Lam CL
Diabetes Obes Metab; 2015 Feb; 17(2):128-35. PubMed ID: 25251664
[TBL] [Abstract][Full Text] [Related]
8. Diabetes Mellitus-Related All-Cause and Cardiovascular Mortality in a National Cohort of Adults.
Raghavan S; Vassy JL; Ho YL; Song RJ; Gagnon DR; Cho K; Wilson PWF; Phillips LS
J Am Heart Assoc; 2019 Feb; 8(4):e011295. PubMed ID: 30776949
[TBL] [Abstract][Full Text] [Related]
9. Association of variability in hemoglobin A1c with cardiovascular diseases and mortality in Chinese patients with type 2 diabetes mellitus - A retrospective population-based cohort study.
Wan EY; Fung CS; Fong DY; Lam CL
J Diabetes Complications; 2016; 30(7):1240-7. PubMed ID: 27318537
[TBL] [Abstract][Full Text] [Related]
10. Multimorbidity, mortality, and HbA1c in type 2 diabetes: A cohort study with UK and Taiwanese cohorts.
Chiang JI; Hanlon P; Li TC; Jani BD; Manski-Nankervis JA; Furler J; Lin CC; Yang SY; Nicholl BI; Thuraisingam S; Mair FS
PLoS Med; 2020 May; 17(5):e1003094. PubMed ID: 32379755
[TBL] [Abstract][Full Text] [Related]
11. Age-specific associations of glycated haemoglobin variability with cardiovascular disease and mortality in patients with type 2 diabetes mellitus: A 10- year cohort study.
Wan EYF; Yu EYT; Chin WY; Ng FTY; Chia SMC; Wong ICK; Chan EWY; Lam CLK
Diabetes Obes Metab; 2020 Aug; 22(8):1316-1327. PubMed ID: 32196917
[TBL] [Abstract][Full Text] [Related]
12. Relation between HbA
Wan EYF; Yu EYT; Fung CSC; Chin WY; Fong DYT; Chan AKC; Lam CLK
Diabetes Metab; 2018 Nov; 44(5):415-423. PubMed ID: 29449147
[TBL] [Abstract][Full Text] [Related]
13. Association of Serum 25-Hydroxyvitamin D With Cardiovascular Outcomes and All-Cause Mortality in Individuals With Prediabetes and Diabetes: Results From the UK Biobank Prospective Cohort Study.
Zhang P; Guo D; Xu B; Huang C; Yang S; Wang W; Liu W; Deng Y; Li K; Liu D; Lin J; Wei X; Huang Y; Zhang H
Diabetes Care; 2022 May; 45(5):1219-1229. PubMed ID: 35226734
[TBL] [Abstract][Full Text] [Related]
14. Risk association of HbA1c variability with chronic kidney disease and cardiovascular disease in type 2 diabetes: prospective analysis of the Hong Kong Diabetes Registry.
Luk AO; Ma RC; Lau ES; Yang X; Lau WW; Yu LW; Chow FC; Chan JC; So WY
Diabetes Metab Res Rev; 2013 Jul; 29(5):384-90. PubMed ID: 23463747
[TBL] [Abstract][Full Text] [Related]
15. Contribution of type 2 diabetes to all-cause mortality, cardiovascular disease incidence and cancer incidence in white Europeans and South Asians: findings from the UK Biobank population-based cohort study.
Muilwijk M; Ho F; Waddell H; Sillars A; Welsh P; Iliodromiti S; Brown R; Ferguson L; Stronks K; van Valkengoed I; Pell JP; Gray SR; Gill JMR; Sattar N; Celis-Morales C
BMJ Open Diabetes Res Care; 2019; 7(1):e000765. PubMed ID: 31908795
[TBL] [Abstract][Full Text] [Related]
16. ASCVD risk stratification modifies the effect of HbA1c on cardiovascular events among patients with type 2 diabetes mellitus with basic to moderate risk.
Zhang H; Qin L; Sheng CS; Niu Y; Gu H; Lu S; Yang Z; Tian J; Su Q
BMJ Open Diabetes Res Care; 2020 Jan; 8(1):. PubMed ID: 31958299
[TBL] [Abstract][Full Text] [Related]
17. Trends of clinical parameters and incidences of diabetes mellitus complications among patients with type 2 diabetes mellitus in Hong Kong, 2010-2019: a retrospective cohort study.
Wang Y; Xu W; Mak IL; Chin WY; Yu EYT; Lam CLK; Wan EYF
EClinicalMedicine; 2023 Jun; 60():101999. PubMed ID: 37234549
[TBL] [Abstract][Full Text] [Related]
18. Age-specific population attributable risk factors for all-cause and cause-specific mortality in type 2 diabetes: An analysis of a 6-year prospective cohort study of over 360,000 people in Hong Kong.
Wu H; Lau ESH; Yang A; Zhang X; Fan B; Ma RCW; Kong APS; Chow E; So WY; Chan JCN; Luk AOY
PLoS Med; 2023 Jan; 20(1):e1004173. PubMed ID: 36716342
[TBL] [Abstract][Full Text] [Related]
19. The Impact of Glycated Hemoglobin (HbA
Au Yeung SL; Luo S; Schooling CM
Diabetes Care; 2018 Sep; 41(9):1991-1997. PubMed ID: 29950300
[TBL] [Abstract][Full Text] [Related]
20. Associations Between Diabetes and Both Cardiovascular Disease and All-Cause Mortality Are Modified by Grip Strength: Evidence From UK Biobank, a Prospective Population-Based Cohort Study.
Celis-Morales CA; Petermann F; Hui L; Lyall DM; Iliodromiti S; McLaren J; Anderson J; Welsh P; Mackay DF; Pell JP; Sattar N; Gill JMR; Gray SR
Diabetes Care; 2017 Dec; 40(12):1710-1718. PubMed ID: 28986505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
